% | $
Quotes you view appear here for quick access.

Aegerion Pharmaceuticals, Inc. (AEGR) Message Board

  • investorguru3742 investorguru3742 Nov 19, 2013 9:24 AM Flag

    Aegerion share weakness overdone, says Leerink

    After speaking with management, Leerink says Aegerion remains confident with the Juxtapid launch and its ability to meet 2013 guidance. The firm views the stock sell-off as overdone and reiterates an Outperform rating on the name with a $106 price target.

    source from theflyonthewall

1.82+0.09(+5.20%)May 27 4:00 PMEDT